The University of Chicago Header Logo

Connection

Hening Lin to Female

This is a "connection" page, showing publications Hening Lin has written about Female.
Connection Strength

0.191
  1. PARP7 inhibition stabilizes STAT1/STAT2 and relieves experimental autoimmune encephalomyelitis in mice. Cell Rep. 2025 Aug 26; 44(8):116130.
    View in: PubMed
    Score: 0.044
  2. Long-chain fatty acyl coenzyme A inhibits NME1/2 and regulates cancer metastasis. Proc Natl Acad Sci U S A. 2022 03 15; 119(11):e2117013119.
    View in: PubMed
    Score: 0.035
  3. A STAT3 palmitoylation cycle promotes TH17 differentiation and colitis. Nature. 2020 10; 586(7829):434-439.
    View in: PubMed
    Score: 0.031
  4. Novel Lysine-Based Thioureas as Mechanism-Based Inhibitors of Sirtuin 2 (SIRT2) with Anticancer Activity in a Colorectal Cancer Murine Model. J Med Chem. 2019 04 25; 62(8):4131-4141.
    View in: PubMed
    Score: 0.028
  5. A SIRT2-Selective Inhibitor Promotes c-Myc Oncoprotein Degradation and Exhibits Broad Anticancer Activity. Cancer Cell. 2016 Mar 14; 29(3):297-310.
    View in: PubMed
    Score: 0.023
  6. Cysteine derivatives as acetyl lysine mimics to inhibit zinc-dependent histone deacetylases for treating cancer. Eur J Med Chem. 2021 Dec 05; 225:113799.
    View in: PubMed
    Score: 0.008
  7. Pharmacological and genetic perturbation establish SIRT5 as a promising target in breast cancer. Oncogene. 2021 03; 40(9):1644-1658.
    View in: PubMed
    Score: 0.008
  8. Non-oncogene Addiction to SIRT3 Plays a Critical Role in Lymphomagenesis. Cancer Cell. 2019 06 10; 35(6):916-931.e9.
    View in: PubMed
    Score: 0.007
  9. Loss of Sirtuin 1 Alters the Secretome of Breast Cancer Cells by Impairing Lysosomal Integrity. Dev Cell. 2019 05 06; 49(3):393-408.e7.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.